Search results for "hospital mortality"

showing 10 items of 196 documents

Do Reduced Hospital Mortality Rates Lead to Increased Utilization of Inpatient Emergency Care?:A Population-Based Cohort Study

2018

OBJECTIVES: To measure the impact of the improvement in hospital survival rates on patients' subsequent utilization of unplanned (emergency) admissions.DATA SOURCES/STUDY SETTING: Unplanned admissions occurring in all acute hospitals of the National Health Service in England between 2000 and 2009, including 286,027 hip fractures, 375,880 AMI, 387,761 strokes, and 9,966,246 any cause admissions.STUDY DESIGN: Population-based retrospective cohort study. Unplanned admissions experienced by patients within 28 days, 1 year, and 2 years of discharge from the index admission are modeled as a function of hospital risk-adjusted survival rates using patient-level probit and negative binomial models. …

Malemedicine.medical_specialtyPopulationHospital mortality030204 cardiovascular system & hematologyPlacebo03 medical and health sciencesPopulation based cohort0302 clinical medicinePatient Admissionhealth care costsMedicineHumans030212 general & internal medicineHospital MortalityhospitalLead (electronics)educationStrokeRisk adjustment for resource use or payment2719AgedRetrospective StudiesHip fractureeducation.field_of_studyInpatientsResource Usebusiness.industryHealth Policyhealth care costRetrospective cohort studyMiddle AgedPatient Acceptance of Health Carequality of care/patient safety (measurement)medicine.diseasePatient DischargeHospitalizationEnglandSettore SECS-P/03 - Scienza Delle FinanzeEmergency medicineFemalebusinessEmergency Service HospitalhospitalsResearch Article
researchProduct

Increasing early ambulation disability in spontaneous intracerebral hemorrhage survivors

2017

ObjectiveTo evaluate temporal trends in early ambulatory status in patients with spontaneous intracerebral hemorrhage (ICH).MethodsAll patients with ICH between 1985 and 2011 were prospectively registered in a population-based registry in Dijon, France, and included in the study. Outcomes of ICH survivors were assessed at discharge from their stay in an acute care ward with the use of a 4-grade ambulation scale. Time trends in ambulation disability and place of discharge were analyzed in 3 periods (1985–1993, 1994–2002, and 2003–2011). Multivariable ordinal and logistic regression models were applied.ResultsFive hundred thirty-one patients with ICH were registered, of whom 200 (37.7%) died …

Malemedicine.medical_specialtyPopulationLogistic regressionCommunity Health Planning03 medical and health sciences0302 clinical medicineInternal medicineAcute caremedicineHumansDisabled PersonsHospital Mortality030212 general & internal medicineSpontaneous intracerebral hemorrhageeducationEarly AmbulationAgedCerebral HemorrhageRetrospective StudiesAged 80 and overeducation.field_of_studybusiness.industryRetrospective cohort studyOdds ratioMiddle AgedPatient DischargeConfidence intervalLogistic ModelsFemaleFranceNeurology (clinical)Ordered logitbusiness030217 neurology & neurosurgeryNeurology
researchProduct

Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicentre Italian CORIST Study

2021

Abstract Introduction A hypercoagulable condition was described in patients with coronavirus disease 2019 (COVID-19) and proposed as a possible pathogenic mechanism contributing to disease progression and lethality. Aim We evaluated if in-hospital administration of heparin improved survival in a large cohort of Italian COVID-19 patients. Methods In a retrospective observational study, 2,574 unselected patients hospitalized in 30 clinical centers in Italy from February 19, 2020 to June 5, 2020 with laboratory-confirmed severe acute respiratory syndrome coronavirus-2 infection were analyzed. The primary endpoint in a time-to event analysis was in-hospital death, comparing patients who receive…

Malemedicine.medical_specialtySettore MED/17 - Malattie Infettivecoronavirusheparin030204 cardiovascular system & hematologyLower risklaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawInternal medicineClinical endpointmedicineHumansThrombophilia030212 general & internal medicineHospital MortalityBlood CoagulationSurvival analysisAgedRetrospective Studiestreatmentbusiness.industryHeparinMortality rateCOVID-19mortalityLow-Molecular-WeightAnticoagulantsCOVID-19Retrospective cohort studyHeparinHematologyHeparin Low-Molecular-WeightMiddle AgedmortalitySurvival AnalysisCOVID-19 Drug Treatmentcoagulation activationcoronaviruItalytreatmentsPropensity score matchingcoagulation activation; coronavirus; COVID-19; heparin; mortality; treatmentsFemalecoagulation activation; coronavirus; COVID-19; heparin; mortality; treatments; Aged; Anticoagulants; Blood Coagulation; COVID-19; Female; Heparin; Heparin Low-Molecular-Weight; Hospital Mortality; Humans; Italy; Male; Middle Aged; Retrospective Studies; Survival Analysis; Thrombophiliabusinessmedicine.drug
researchProduct

Sex-specific differences drive temporal trends and outcomes of patients hospitalized for heart failure in Germany

2020

Despite remarkable improvements in treatment of cardiovascular disease, heart failure (HF) is still characterized by high mortality rate. Sex-specific differences in HF have been described, but underlying reasons are widely unexplored.The nationwide German inpatient sample (2005-2016) was used for this sex-specific analyses. Temporal trends on hospitalizations, mortality, and treatments were analysed and independent predictors of adverse outcomes identified.The analysis comprises 4,538,977 hospitalizations due to HF (52.0%women) in Germany (2005-2016). Although women were older (median 82(IQR75-87) vs.76(69-82),P  0.001), coronary artery disease (CAD, 50.3% vs. 30.7%,P  0.001) was more prev…

Malemedicine.medical_specialtyTime FactorsDatabases FactualAdverse outcomesMEDLINEDisease030204 cardiovascular system & hematologyRisk Assessment03 medical and health sciencesSex Factors0302 clinical medicineGermanyInternal medicineCase fatality ratePrevalencemedicineHumansHospital Mortality030212 general & internal medicineHealthcare DisparitiesAgedAged 80 and overHeart Failurebusiness.industryIncidenceMortality rateIncidence (epidemiology)Health Status Disparitiesmedicine.diseaseSex specificHospitalizationOutcome and Process Assessment Health CareTreatment OutcomeHeart Disease Risk FactorsHeart failureFemaleCardiology and Cardiovascular MedicinebusinessProgress in Cardiovascular Diseases
researchProduct

Prognostic Value of White Blood Cell Count in Acute Myocardial Infarction: Long-Term Mortality

2005

Although traditionally an elevated white blood cell count (WBC), an indicator of systemic inflammation, has been accepted as part of the healing response following acute myocardial infarction (AMI), it has frequently been shown to be a predictor of adverse cardiovascular events. The present study was designed to assess the association between WBC and long-term mortality in AMI patients either with ST-segment elevation (STEMI) or without ST-segment elevation (non-STEMI). Patients and method. The study included 1118 consecutive patients who were admitted with the diagnosis of AMI: 569 non-STEMI and 549 STEMI. The WBC was measured in the 24 hours following admission. Patients were divided into…

Malemedicine.medical_specialtyTime FactorsMyocardial InfarctionSystemic inflammationElectrocardiographyLeukocyte CountRisk FactorsInternal medicineWhite blood cellMyocardial RevascularizationmedicineHumansHospital Mortalitycardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronarySurvival analysisAgedProportional Hazards Modelsmedicine.diagnostic_testbusiness.industryProportional hazards modelHazard ratioGeneral MedicinePrognosismedicine.diseaseSurvival AnalysisSurgerysurgical procedures operativemedicine.anatomical_structureCardiologyRegression AnalysisFemaleLong term mortalitymedicine.symptombusinessElectrocardiographyFollow-Up StudiesRevista Española de Cardiología (English Edition)
researchProduct

In-hospital outcomes and 5-year mortality following an acute myocardial infarction in patients with a history of cancer: Results from the French regi…

2019

Summary Background Cancer and acute myocardial infarction (AMI) have important prognostic consequences. Treatment of some cancers may affect coronary artery disease, myocardial function and/or AMI management. Whether the early and long-term mortality of patients with AMI differ according to their history of cancer remains questionable. Aims To determine in-hospital outcomes and 5-year mortality following AMI according to patient history of cancer. Methods The FAST-MI registry is a nationwide French survey collecting data on characteristics, management and outcomes of 3670 consecutive patients admitted for AMI during October 2005. Results Overall, 246/3664 patients (6.7%) admitted for an AMI…

Malemedicine.medical_specialtyTime Factors[SDV]Life Sciences [q-bio]Infarctus du myocardeAcute myocardial infarction030204 cardiovascular system & hematologyMortalitéRisk AssessmentCoronary artery disease03 medical and health sciences0302 clinical medicineRisk FactorsNeoplasmsInternal medicineMortalité hospitalière.medicineHumansMedical historyHospital MortalityProspective StudiesRegistries030212 general & internal medicineMyocardial infarctioncardiovascular diseasesRisk factorMortalityNon-ST Elevated Myocardial InfarctionAgedCancerAged 80 and overbusiness.industryST elevationHazard ratioGeneral MedicineOdds ratioMiddle Agedmedicine.disease3. Good healthHospitalization[SDV] Life Sciences [q-bio]In-hospital mortalityTreatment OutcomeCohortST Elevation Myocardial InfarctionFemaleFranceCardiology and Cardiovascular Medicinebusiness
researchProduct

Outcomes of a routine invasive strategy in elderly patients with non-ST-segment elevation myocardial infarction from 2005 to 2014: results from the P…

2019

Background Elderly patients (≥75 years old) with non-ST-segment elevation myocardial infarction (NSTEMI) represent a large subgroup of all cases. They are rarely included in randomized trials because of comorbidities and concerns about complications. Furthermore, invasive treatments are used less frequently in this patient group. The aim of this study was to analyze trends in invasive procedures and outcomes in elderly patients with NSTEMI from 2005 to 2014. Patients and methods We analyzed 68 978 elderly patients with NSTEMI enrolled in the prospective, nationwide Polish Registry of Acute Coronary Syndromes from 2005 to 2014. Results Elderly patients accounted for 34.9% of all patients wit…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyRisk Assessmentlaw.invention03 medical and health sciences0302 clinical medicinePercutaneous Coronary InterventionSex FactorsRandomized controlled triallawPredictive Value of TestsRisk FactorsInternal medicinemedicineST segmentHumans030212 general & internal medicineMyocardial infarctionHospital MortalityRegistriesHealthcare DisparitiesNon-ST Elevated Myocardial InfarctionAgedbusiness.industryAge FactorsPercutaneous coronary interventionGeneral MedicineMiddle Agedmedicine.diseaseConfidence intervalStandardized mortality ratioTreatment OutcomePredictive value of testsRelative riskFemalePolandCardiology and Cardiovascular MedicinebusinessCoronary artery disease
researchProduct

Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany.

2019

Abstract Aims Pulmonary embolism (PE) is the third most common cardiovascular cause of death; systemic thrombolysis is potentially lifesaving treatment in patients presenting with haemodynamic instability. We investigated trends in the use of systemic thrombolysis and the outcome of patients with acute PE. Methods and results We analysed data on the characteristics, comorbidities, treatment, and in-hospital outcome of 885 806 PE patients in Germany between 2005 and 2015. Incidence of acute PE was 99/100 000 population/year and increased from 85/100 000 in 2005 to 109/100 000 in 2015 [β 0.32 (0.26–0.38), P < 0.001]. During the same period, in-hospital case fatality rates decreased fro…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRisk FactorsInternal medicineGermanyCase fatality ratemedicineHumansThrombolytic TherapyCardiopulmonary resuscitationHospital MortalityeducationCause of deathAgedRetrospective StudiesAged 80 and overeducation.field_of_studybusiness.industryMortality rate030229 sport sciencesThrombolysisMiddle Agedmedicine.diseasePulmonary embolismTreatment OutcomeAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessPulmonary EmbolismFibrinolytic agentFollow-Up StudiesEuropean heart journal
researchProduct

Impact of prehospital delay on mortality in patients with acute myocardial infarction treated with primary angioplasty and intravenous thrombolysis.

2001

Abstract Background In patients with acute myocardial infarction treated with thrombolysis, longer times to treatment are associated with increasingly worse clinical outcome. This relation may be different for treatment with primary angioplasty. Methods We analyzed the pooled data of the German acute myocardial infarction registries Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) and Myocardial Infarction Registry (MIR) to determine the influence of prehospital delays on hospital mortality rates. Primary angioplasty was performed in 1063 patients and thrombolysis in 7552 patients. Results In patients treated with thrombolysis, in-hospital time to treatment was constantly 3…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentTime to treatmentPrimary angioplastyMyocardial InfarctionStatistics NonparametricInternal medicineFibrinolysismedicineHumansIn patientThrombolytic TherapyMyocardial infarctionHospital MortalityProspective StudiesRegistriesChemotherapyChi-Square Distributionbusiness.industryMortality rateThrombolysisMiddle Agedmedicine.diseaseSurgeryTreatment OutcomeCardiologyFemaleCardiology and Cardiovascular MedicinebusinessAngioplasty BalloonAmerican heart journal
researchProduct

Psoriasis and its impact on the clinical outcome of patients with pulmonary embolism

2021

Abstract Background Venous thromboembolism (VTE) is common and associated with high morbidity and mortality. Although chronic inflammation was not categorized as a traditional risk factor for VTE, chronic inflammation might increase the risk to develop VTE events. While studies confirmed an increased cardiovascular morbidity and mortality in psoriatic patients, data regarding the influence of psoriasis on patients' cardiovascular profile and on prognosis of patients with pulmonary embolism (PE) are sparse. Purpose We aimed to investigate the impact of psoriasis on prognosis of PE patients. Methods Hospitalized PE patients were stratified for psoriasis and the impact of psoriasis on outcome …

Malemedicine.medical_specialtyYounger agebusiness.industryVenous Thromboembolismmedicine.diseasePulmonary embolismVenous thrombosisIncreased riskRisk FactorsInternal medicinePsoriasismedicineHumansPsoriasisFemaleHospital MortalityPulmonary EmbolismCardiology and Cardiovascular MedicinebusinessVenous thromboembolismAgedEuropean Heart Journal
researchProduct